Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T16:33:11.249Z.
Calculation as of: 2026-10-06T16:33:11.249Z.
Quote observation: 2026-10-06T16:22:51.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 04c3f12431ab3e8d6f15e27a04b3f35a1ccc42ae6fada6e5bc04b9c12e20bb1c
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Market Cap
$17.01M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.76M
Operating Cash Flow Yield
N/A
TTM Avg
0.64%
3Y Avg
0.50%
5Y Avg
0.42%
Market Cap
$16.75M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$17.81M
Operating Cash Flow Yield
N/A
TTM Avg
7.24%
3Y Avg
5.87%
5Y Avg
5.87%
Market Cap
$16.48M
Operating Cash Flow Yield
N/A
TTM Avg
2.46%
3Y Avg
5.67%
5Y Avg
4.13%
Market Cap
$15.93M
Operating Cash Flow Yield
N/A
TTM Avg
4.27%
3Y Avg
3.48%
5Y Avg
4.26%
Market Cap
$18.60M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lipocine Inc. (LPCN) | $17.19M | N/A | N/A | N/A | N/A |
| PAVmed Inc. (PAVM)vs › | $17.17M | N/A | N/A | N/A | N/A |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.01M | N/A | N/A | N/A | N/A |
| Palatin Technologies, Inc. (PTN)vs › | $16.76M | N/A | 0.64% | 0.50% | 0.42% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.75M | N/A | N/A | N/A | N/A |
| Cosmos Health Inc. (COSM)vs › | $17.81M | N/A | 7.24% | 5.87% | 5.87% |
| Dyadic International, Inc. (DYAI)vs › | $16.48M | N/A | 2.46% | 5.67% | 4.13% |
| BioCardia, Inc. (BCDA)vs › | $15.93M | N/A | 4.27% | 3.48% | 4.26% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.60M | N/A | N/A | N/A | N/A |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.60M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
